世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ボーングラフトと代用品。グローバルマーケット

ボーングラフトと代用品。グローバルマーケット


Bone Grafts and Substitutes: Global Markets

概要 世界の骨移植・代替品市場は、2020年にREDACTED億ドルとなりました。この市場は、年平均成長率(CAGR)がREDACTED%で推移し、2026年には約REDACTED億ドルに達すると予測されています。このセグメントの... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
BCC Research
BCCリサーチ
2021年11月30日 US$5,500
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
2-3営業日以内 181 英語

 

サマリー

概要

世界の骨移植・代替品市場は、2020年にREDACTED億ドルとなりました。この市場は、年平均成長率(CAGR)がREDACTED%で推移し、2026年には約REDACTED億ドルに達すると予測されています。このセグメントの高い成長率は、米国、欧州、アジアの一部の国における骨移植・代替品の需要、慢性疾患の増加、前十字靭帯(ACL)の普及などの要因に起因しています。このセグメントの高い成長率は、米国、欧州および一部のアジア諸国における骨移植および代替品の需要、慢性疾患の増加、前十字靭帯再建術の普及、骨および筋骨格系の移植の増加、スポーツ医学および脊椎・神経学の拡大、事故による重大なまたは生命を脅かす障害の治療に大きく使用されていることなどの要因によるものです。

主要市場のプレーヤーは、グローバス・メディカル、インテグラ・ライフサイエンス、パターソン・カンパニーズ・インク、シースピン、デンツプライ・シロナ、アロソース・インク、ジマー・バイオメット・ホールディングス、インスティトゥート・ストラウマンAG、ジョンソン・エンド・ジョンソン、アニカ・セラピューティクスなどです。

人工股関節置換術は比較的高額ですが、通常は民間の保険会社や国の医療保険制度でカバーされています。2017年、米国およびEUにおける股関節置換術の費用は、約REDACTED~REDACTED(病院および医師の料金を含む)でした。米国およびEU以外の国に渡航して手術を受ければ、REDACTED%を節約できます。関節置換手術は、極度の骨や関節の障害に苦しむ人々にとって、動けなくなるか、充実した生活を送れるかの分かれ目となります。毎年、米国では約REDACTEDの人工股関節置換術と約REDACTEDの人工膝関節置換術が行われています。

高い成長率は、米国、欧州、一部のアジア諸国における審美手術用の骨移植片の需要、歯科疾患の増加、粘膜歯肉手術の発生率と審美的需要の増加、インプラント歯科治療のための軟組織増強、事故による治療への大きな使用などに起因しています。

ページTOPに戻る


目次

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Bone Graft and Substitutes: Overview
Cost of Care
Solid Organ Preservation
Ideal Bone Grafting Material
Natural Bone Graft and Substitute Materials
Synthetic Bone Substitute Materials
Composite Bone Substitute Materials
Bone Substitutes with Infused Living Osteogenic Cells
Trends in Bone Graft and Substitutes Market
3D Tissue Assembly
Nanotechnology
Innovation from Small Firms
Chapter 4 Market Dynamics
Market Drivers
Rapid Development, Dental Technology
Elder Population
Sport Injuries
Disposable Income
Market Restraints
Government Approval
Lower Outcomes
Market Opportunities
Launches, Mergers and Acquisitions (M&A)
Cosmetic Dentistry
Chapter 5 Market Breakdown, by Product
Introduction
Orthopedic Alternatives
Global Market for Bone Graft and Substitutes
Synthetic Bone Substitutes
Market Size and Forecast
Natural Bone Grafts
Market Size and Forecast
Chapter 6 Market Breakdown, by Synthetic Bone Substitute
Composite Bone Substitutes
Market Size and Forecast
Growth Factor Substitutes
Market Size and Forecast
Bone Substitutes with Living Cells
Market Size and Forecast
Chapter 7 Market Breakdown, by Natural Bone Graft
Xenografts
Market Size and Forecast
Autograft
Market Size and Forecast
Allograft
Classification of Bone Grafts Based on Material Groups:
Market Size and Forecast
Phytogenic Materials
Market Size and Forecast
Chapter 8 Market Breakdown, by Region
Global Market for Bone Graft and Substitutes, by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Analysis
Brazil
Argentina
Rest of Latin American Countries
Middle East and Africa
Market Analysis
GCC Countries
South Africa
Rest of Middle East and African Countries
Chapter 9 Impact of COVID-19
Introduction
Minimizing Infection Risk in Recipients
Donor selection criteria:
Future Perspectives
Chapter 10 Regulations & Reimbursement
Regulations in the U.S.
U.S. Federal Regulation of Human Tissue
History of Regulation in the U.S.
Regulations Outside the U.S.
Reimbursement in the U.S.
Organ Acquisition Costs
Reimbursement for Hospital Costs
Reimbursement for Physician Services
Reimbursement for Immunosuppressants in the U.S.
Reimbursement Outside the U.S.
Treatment in EU Countries
Chapter 11 Competitive Landscape
Global Analysis of Companies
Mergers and Acquisitions
Agreements, Launches, Collaborations and Partnerships
Chapter 12 Company Profiles
ALLOSOURCE INC.
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BIOHORIZONS IPH
BIOTISSUE TECHNOLOGIES GMBH
COOK MEDICAL INC.
DENTSPLY SIRONA
GLOBUS MEDICAL INC.
INTEGRA LIFESCIENCES CORP.
JOHNSON & JOHNSON
PATTERSON COMPANIES INC.
SEASPINE
STRAUMANN HOLDING AG.
ZIMMER BIOMET HOLDINGS
Chapter 13 Appendix: Acronyms

 

ページTOPに戻る


 

Summary

Summary:

The global bone graft and substitutes market was valued at $REDACTED billion in 2020. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach approximately $REDACTED billion by 2026.The high growth rate of this segment is attributed to factors such as demand for bone graft and substitutes in the U.S., Europe and some Asian countries; a rise in chronic diseases; increased prevalence of anterior cruciate ligament (ACL) reconstruction; increasing bone and musculoskeletal transplants;expansion of sports medicine and spine/neurology and significant use treating prominent or life-threatening disorders caused by accidents.

The key market players include Globus Medical, Integra Lifescience, Patterson Companies Inc., Seaspine, Dentsply Sirona, AlloSource Inc., Zimmer Biomet Holdings, Institut Straumann AG, Johnson & Johnson and Anika Therapeutics.

Hip replacement surgeries are relatively expensive, but are usually covered by private insurance companies and national healthcare plans. In 2017, a hip replacement in the U.S. and EU cost about $REDACTED to $REDACTED (including hospital and physician charges). Travel to countries outside the U.S. and EU for the surgery could save REDACTED%. Joint-replacement surgery can be the difference between immobility and a full life for people suffering from extreme bone and joint disorders. Every year thereare about REDACTED hip replacements and REDACTED knee replacements performed in the U.S.

The high growth rate is attributed to demand for bone allografts for aesthetic surgery in the U.S., Europe and some Asian countries; a rise in dental diseases; increased incidence of mucogingival surgery and aesthetic demand; soft tissue augmentation for implant dentistry and significant use for treatment due to accidents.



ページTOPに戻る


Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Bone Graft and Substitutes: Overview
Cost of Care
Solid Organ Preservation
Ideal Bone Grafting Material
Natural Bone Graft and Substitute Materials
Synthetic Bone Substitute Materials
Composite Bone Substitute Materials
Bone Substitutes with Infused Living Osteogenic Cells
Trends in Bone Graft and Substitutes Market
3D Tissue Assembly
Nanotechnology
Innovation from Small Firms
Chapter 4 Market Dynamics
Market Drivers
Rapid Development, Dental Technology
Elder Population
Sport Injuries
Disposable Income
Market Restraints
Government Approval
Lower Outcomes
Market Opportunities
Launches, Mergers and Acquisitions (M&A)
Cosmetic Dentistry
Chapter 5 Market Breakdown, by Product
Introduction
Orthopedic Alternatives
Global Market for Bone Graft and Substitutes
Synthetic Bone Substitutes
Market Size and Forecast
Natural Bone Grafts
Market Size and Forecast
Chapter 6 Market Breakdown, by Synthetic Bone Substitute
Composite Bone Substitutes
Market Size and Forecast
Growth Factor Substitutes
Market Size and Forecast
Bone Substitutes with Living Cells
Market Size and Forecast
Chapter 7 Market Breakdown, by Natural Bone Graft
Xenografts
Market Size and Forecast
Autograft
Market Size and Forecast
Allograft
Classification of Bone Grafts Based on Material Groups:
Market Size and Forecast
Phytogenic Materials
Market Size and Forecast
Chapter 8 Market Breakdown, by Region
Global Market for Bone Graft and Substitutes, by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Analysis
Brazil
Argentina
Rest of Latin American Countries
Middle East and Africa
Market Analysis
GCC Countries
South Africa
Rest of Middle East and African Countries
Chapter 9 Impact of COVID-19
Introduction
Minimizing Infection Risk in Recipients
Donor selection criteria:
Future Perspectives
Chapter 10 Regulations & Reimbursement
Regulations in the U.S.
U.S. Federal Regulation of Human Tissue
History of Regulation in the U.S.
Regulations Outside the U.S.
Reimbursement in the U.S.
Organ Acquisition Costs
Reimbursement for Hospital Costs
Reimbursement for Physician Services
Reimbursement for Immunosuppressants in the U.S.
Reimbursement Outside the U.S.
Treatment in EU Countries
Chapter 11 Competitive Landscape
Global Analysis of Companies
Mergers and Acquisitions
Agreements, Launches, Collaborations and Partnerships
Chapter 12 Company Profiles
ALLOSOURCE INC.
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BIOHORIZONS IPH
BIOTISSUE TECHNOLOGIES GMBH
COOK MEDICAL INC.
DENTSPLY SIRONA
GLOBUS MEDICAL INC.
INTEGRA LIFESCIENCES CORP.
JOHNSON & JOHNSON
PATTERSON COMPANIES INC.
SEASPINE
STRAUMANN HOLDING AG.
ZIMMER BIOMET HOLDINGS
Chapter 13 Appendix: Acronyms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

BCC Research社の